Khaykin, Yaariv

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Anand, S. S., Bosch, J., Eikelboom, J. W., Connolly, S. J., Diaz, R., Widimsky, P., Aboyans, V., Alings, M., Kakkar, A. K., Keltai, K., et al. (2018) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 879

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Connolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 754

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Andrade, J. G., Deyell, M. W., Macle, L., Wells, G. A., Bennett, M., Essebag, V., Champagne, J., Roux, J.-F., Yung, D., Skanes, A., et al. (2023) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 385

Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF): A Prospective, Multicenter Study

Verma, A., Champagne, J., Sapp, J., Essebag, V., Novak, P., Skanes, A., Morillo, C. A., Khaykin, Y., & Birnie, D. (2013) · JAMA Internal Medicine

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 315

Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses

KHAYKIN, Y., MARROUCHE, N. F., MARTIN, D. O., SALIBA, W., SCHWEIKERT, R., WEXMAN, M., STRUNK, B., BEHEIRY, S., SAAD, E., BHARGAVA, M., et al. (2004) · Journal of Cardiovascular Electrophysiology

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 49

Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy

Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 44

Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation

Shamiss, Y., Khaykin, Y., Oosthuizen, R., Tunney, D., Sarak, B., Beardsall, M., Seabrook, C., Frost, L., Wulffhart, Z., Tsang, B., et al. (2009) · EP Europace

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 17